Font: Financial Modeling Prep • Apr 01, 2026
Lamb Weston Holdings, Inc. (NYSE: LW) is a global leader in frozen potato products and other frozen food items, serving quick-service restaurants, foodservice operators, and retail customers worldwide.
On April 1, 2026, the company reported fiscal third-quarter 2026 results. Revenue showed resilience with $1.56 billion in net sales, driven by strong volume growth (particularly in North America) that offset softer price/mix and competitive pressures in certain international markets.
While top-line performance beat expectations, profitability faced headwinds. Adjusted EBITDA came in at $271.7 million. For the first nine months of fiscal 2026, net sales totaled $4.84 billion (up 1% year-over-year).
Despite the year-over-year profit declines, management demonstrated confidence by increasing the midpoint of its full-year fiscal 2026 net sales and adjusted EBITDA outlook and reducing projected capital expenditures. The company also declared a quarterly dividend of $0.38 per share.
Lamb Weston continues to focus on volume growth, operational efficiencies, and long-term cost-saving initiatives amid a challenging environment of input cost volatility and shifting consumer demand.
|
GV§>
Visionary Holdings Inc.
|
$0.44
116.78%
|
|
LNKS§>
Linkers Industries Limited
|
$0.01
-35.16%
|
|
AIXI§>
Xiao-I Corporation
|
$0.13
33.10%
|
|
SKYQ§>
Sky Quarry Inc.
|
$5.10
101.58%
|
|
NVDA§>
NVIDIA Corporation
|
$177.39
0.93%
|
|
BITO§>
ProShares - Bitcoin ETF
|
$9.21
-1.60%
|
|
COCP§>
Cocrystal Pharma, Inc.
|
$1.51
48.04%
|
|
TSLL§>
Direxion Daily TSLA Bull 2X ETF
|
$11.37
-10.96%
|
|
SPDN§>
Direxion Daily S&P 500 Bear 1X ETF
|
$9.87
0.10%
|
|
BDRX§>
Biodexa Pharmaceuticals Plc
|
$0.87
42.23%
|